Seeking Alpha

GE HealthCare Announces FDA Approval of Pediatric Indication for Optison Ultrasound Enhancing Agent

The latest approval will help provide clearer echocardiogram images for cardiologists to diagnose heart conditions in pediatric patients Optison is the only polyethylene glycol (PEG)-free ultrasound ...
Business Wire

GE Healthcare Medical Diagnostics Relaunches Optison™ Contrast Agent in Europe | Business Wire

Optison is an ultrasound contrast agent available in a ready-to-use formulation, providing the benefits of fast preparation time, ease of use, portability, and flexible dosing. 2 The recommended dose ...
Nasdaq

GE Healthcare Receives FDA Approval for Change in Contraindications in Prescribing Information for OptisonTM

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- GE Healthcare announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to remove hypersensitivity to ‘blood and blood ...
Nasdaq

GE HealthCare Stock May Gain as FDA Approves Optison for Pediatric Use

GE HealthCare Technologies Inc. GEHC recently announced FDA approval for Optison, its polyethylene glycol (PEG)-free ultrasound enhancing agent, for use in pediatric patients. This milestone expands ...
Business Wire

GE Healthcare Receives FDA Approval for Change in Contraindications in Prescribing Information for Optison TM

MARLBOROUGH, Mass.--(BUSINESS WIRE)--GE Healthcare announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to remove hypersensitivity to ‘blood and blood ...